Effectiveness of Mobilization With Movement (MWM) on Patients With Knee Osteoarthritis (OA): A Double-blinded Randomized Sham-controlled Trial
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Knee Osteoarthritis
- Sponsor
- The Hong Kong Polytechnic University
- Enrollment
- 40
- Locations
- 1
- Primary Endpoint
- Change of pain in the Visual Analogue Scale (VAS)
- Status
- Active, Not Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
Movement with mobilization (MWM) is an effective manual therapy to improve pain and function of patients with knee osteoarthritis (OA).
However, immediate, and prolonged effects after prolonged MWM period was under-investigated.
In this double-blinded randomized control trial, 40 patients are needed. The subjects and assessors will be blinded. Subjects in intervention group will receive MWM twice a week and corresponding home exercise for 6 weeks.
Participants in control group will only receive sham treatment with light touch.
The effects on knee pain in visual analogue scale (VAS); flexion and extension range of motion (ROM) by goniometer; strength by hand-held dynamometer; function by Timed Up and Go Test (TUG) and 30-second Chair Stand Test; and health-related quality of life (HRQoL) by Knee Injury and Osteoarthritis Outcome Score (KOOS) and Western Ontario and McMaster Universities Arthritis Index (WOMAC) just after, 1-month and 3-month after treatment will be compared with baseline. Six-month after treatment, KOOS and WOMAC will be conducted.
Investigators
Eligibility Criteria
Inclusion Criteria
- •History of knee OA for at least 1-year
- •Pain intensity level ≥ 3 on a 10-cm Visual Analogue Scale (VAS)
- •Both unilateral or bilateral knee pain
- •Having morning stiffness less than 30 minutes
- •Having crepitus on active movement
- •Having bony tenderness
- •Having bony enlargement
Exclusion Criteria
- •Having active inflammatory or infectious knee conditions
- •Having bone integrity conditions like osteoporosis
- •Having knee joint instability
- •Having skin integrity conditions like frail skin or lower limb peripheral vascular disease
- •History of hip or knee fracture
- •History of knee surgical history
- •Use of knee corticosteroid or opioid injection
Outcomes
Primary Outcomes
Change of pain in the Visual Analogue Scale (VAS)
Time Frame: The change before the start of treatment and 3-month after last treatment session
Subjects will indicate the pain level on a 100-millimeter line with endpoints, marked "no pain" and "worst imaginable pain", at the time of assessment.
Secondary Outcomes
- Change of time used in the Timed Up and Go Test (TUG)(The change before the start of treatment and 3-month after last treatment session)
- Change of number of repetitions in the 30-second Chair Stand Test (30CST)(The change before the start of treatment and 3-month after last treatment session)
- Change of knee flexors muscle strength by the hand-held dynamometer(The change before the start of treatment and 3-month after last treatment session)
- Change of knee extensors muscle strength by the hand-held dynamometer(The change before the start of treatment and 3-month after last treatment session)
- Change of score of the Knee Injury and Osteoarthritis Outcome Score (KOOS)(The change before the start of treatment and 6-month after last treatment session)
- Change of score of the Western Ontario and McMaster Universities Arthritis Index (WOMAC)(The change before the start of treatment and 6-month after last treatment session)
- Change of active knee flexion range of motion by the standard goniometer(The change before the start of treatment and 3-month after last treatment session)
- Change of active knee extension range of motion by the standard goniometer(The change before the start of treatment and 3-month after last treatment session)